Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1541.2000 -12.20 (-0.79%)
NSE Sep 08, 2025 15:31 PM
Volume: 588.5K
 

logo
Cipla Ltd.
08 Nov 2017, 09:58AM
1541.20
-0.79%
HDFC Securities
Maintain NEUTRAL rating with a TP of Rs 630 (20x Sep-19E). Ciplas overall performance was in-line with expectations in 2QFY18, as the company reaped the benefits of post-GST channel re-stocking. The top-line came in at Rs 40.8bn, ~9% up YoY. This was boosted by the domestic business, which grew 12% YoY (both in-line with estimates). EBITDA was Rs 8bn, up 18% YoY. The margin was 19.7%, up ~160bps YoY, driven by operating leverage and a favourable business mix. PAT was up 19% YoY at Rs 4.2bn.
Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
More from Cipla Ltd.
Recommended